Lion Point Capital, LP AVDL Holdings History
Lion Point Capital, LP's Avadel Pharmaceuticals PLC Holding Summary
As of 2025-03-31, Lion Point Capital, LP held 98,700.00 shares of Avadel Pharmaceuticals PLC(AVDL), totaling $772,820.00. This investment constitutes 4.93% of their stock portfolio, and Lion Point Capital, LP now holds 0.1% of the outstanding Avadel Pharmaceuticals PLC(AVDL) stock.
The initial trade took place in 2023Q3. And since then Lion Point Capital, LP has made 3 purchases of AVDL, at an average price of $11.94, for a total of 117,200.00 shares. In addition, there have been 1 sales at an average price of $15.23 for 18,500.00 shares. Based on historical transaction data and AVDL's current price of $8.93, Lion Point Capital, LP's estimated gain on his AVDL holdings is $-235,718.00, reflecting a -16.85% gain to date.
Lion Point Capital, LP AVDL ($8.93) Holding Chart
Lion Point Capital, LP AVDL ($8.93) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
